BioXcel Therapeutics, Inc. Human Resources Contracts & Agreements
37 Contracts & Agreements
- Bonus & Incentive Agreements (8 contracts)
- Compensation Agreements (1)
- Consulting Agreements (1)
- Employment Agreements (20)
- Non-Competition Agreements (1)
- Separation Agreements (6)
- Amendment to Executive Employment Agreement dated January 7, 2025 by and between BioXcel Therapeutics, Inc. and Frank Yocca (Filed With SEC on January 8, 2025)
- Amendment to Executive Employment Agreement dated January 7, 2025 by and between BioXcel Therapeutics, Inc. and Richard Steinhart (Filed With SEC on January 8, 2025)
- Amendment to Executive Employment Agreement dated January 7, 2025 by and between BioXcel Therapeutics, Inc. and Vimal Mehta (Filed With SEC on January 8, 2025)
- Addendum to Employment Agreement – Richard Steinhart (Filed With SEC on November 14, 2024)
- Addendum to Employment Agreement – Frank Yocca (Filed With SEC on November 14, 2024)
- Addendum to Employment Agreement – Vince O'Neill (Filed With SEC on November 14, 2024)
- Addendum to Employment Agreement – Vimal Mehta (Filed With SEC on November 14, 2024)
- Consulting Agreement between BioXcel Therapeutics, Inc. and Matthew Wiley, dated October 8, 2024 (Filed With SEC on October 9, 2024)
- Separation Agreement between BioXcel Therapeutics, Inc. and Matthew Wiley, dated October 3, 2024 (Filed With SEC on October 9, 2024)
- Non-Compete Agreement, by and among the Company, Dr. Krishnan Nandabalan, InveniAI LLC, Invea Therapeutics, Inc. and the other parties thereto, dated September 19, 2023 (Filed With SEC on September 25, 2023)
- Form of RSU Agreement pursuant to the OnkosXcel Therapeutics, LLC and OnkosXcel Employee Holdings, LLC Management Incentive Plan (Filed With SEC on May 9, 2023)
- Employment Agreement, dated July 1, 2022, by and between BioXcel Therapeutics, Inc. and Vincent ONeill, M.D (Filed With SEC on May 9, 2023)
- Form of Profits Interest Award Agreement under the Management Incentive Plan (Filed With SEC on August 19, 2022)
- OnkosXcel Therapeutics LLC and OnkosXcel Employee Holdings LLC Management Incentive Plan (Filed With SEC on August 19, 2022)
- Second Amendment to the Second Amended and Restated Separation and Shared Services Agreement, between the Company and BioXcel LLC, dated April 19, 2022 (Filed With SEC on May 9, 2022)
- Employment Agreement between Matthew Wiley and BioXcel Therapeutics, Inc., dated January 12, 2022 (Filed With SEC on March 11, 2022)
- Separation Agreement and General Release between Reina Benabou and BioXcel Therapeutics, Inc., dated July 28, 2021 (Filed With SEC on August 10, 2021)
- Employment Agreement between Javier Rodriguez and BioXcel Therapeutics, Inc., dated February 15, 2021 (Filed With SEC on March 12, 2021)
- First Amendment to Second Amended and Restated Separation and Shared Services Agreement, dated March 3, 2021, by and between BioXcel LLC and BioXcel Therapeutics Inc (Filed With SEC on March 12, 2021)
- Employment Agreement between Reina Benabou and BioXcel Therapeutics, Inc., dated June 21, 2020 (Filed With SEC on August 14, 2020)
- Employment Agreement between William Kane and BioXcel Therapeutics, Inc., dated May 15, 2020 (Filed With SEC on August 14, 2020)
- BioXcel Therapeutics, Inc. 2020 Incentive Award Plan and forms of award agreements thereunder (Filed With SEC on August 14, 2020)
- BioXcel Therapeutics, Inc. 2020 Incentive Award Plan (Filed With SEC on May 21, 2020)
- Non-Employee Director Compensation Program (Filed With SEC on May 12, 2020)
- Second Amended and Restated Separation and Shared Services Agreement, dated March 6, 2020, by and between BioXcel Corporation and BioXcel Therapeutics, Inc (Filed With SEC on March 9, 2020)
- Executive Employment Agreement, dated June 1, 2018, by and between BioXcel Therapeutics, Inc. and Dr. Vincent ONeill, M.D (Filed With SEC on June 7, 2018)
- Executive Employment Agreement, by and between BioXcel Therapeutics, Inc. and Vimal Mehta (Filed With SEC on March 13, 2018)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 5, 2018)
- Employment Agreement, effective October 2, 2017, by and between BioXcel Therapeutics, Inc. and Richard Steinhart (Filed With SEC on February 12, 2018)
- Employment Agreement, dated February 12, 2018, by and between BioXcel Therapeutics, Inc. and Frank Yocca (Filed With SEC on February 12, 2018)
- Form of Employment Agreement by and between BioXcel Therapeutics, Inc. and Vimal Mehta, to be effective on the effective date of the registration statement (Filed With SEC on February 12, 2018)
- First Amendment to Employment Agreement, dated December 21, 2017, by and between BioXcel Corporation and Vimal Mehta (Filed With SEC on February 12, 2018)
- Employment Agreement, effective September 1, 2014, by and between BioXcel Corporation and Vimal Mehta (Filed With SEC on February 12, 2018)
- Form of Non-Statutory Stock Option Agreement under the 2017 Equity Incentive Plan (Filed With SEC on February 12, 2018)
- Form of Incentive Stock Option Agreement under the 2017 Equity Incentive Plan (Filed With SEC on February 12, 2018)
- 2017 Equity Incentive Plan (Filed With SEC on February 12, 2018)
- Amended and Restated Separation and Shared Services Agreement, effective November 7, 2017, by and between BioXcel Corporation and BioXcel Therapeutics, Inc (Filed With SEC on February 12, 2018)
